Agro Tech Farm

Agro Tech Farm

ICO Ended
8,843 Views
Unlike other types of growers ATF home farm does not require professional agronomic skills either specific knowledge regarding vegetation process. All operations related to photosynthesis are scripted and fully automated. Our customer may easily control and monitor cultivation cycles by smartphone. There are two vegetation cells which allow to grow two large plants in sequence.
6.2
TOTAL SCORE
5
ICO PROFILE

(weight: 45%)

9
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Pre-sale Time: 24 Dec 2017 - 10 Jan 2018
ICO Time: 01 Feb 2018 - 28 Feb 2018
Whitelist/KYC: Whitelist + KYC
Country: Estonia
Token info
Ticker: ATF
Platform: Ethereum
Token Type: ERC20
Financial
Pre-sale Price : 1 ATF = 0.008 ETH
Accepting: ETH
Soft cap: 1500 ETH
Hard cap: 10000 ETH
2014 November-December
An idea of indoor home farms generation. <br /> <br /> Market evaluation, R&D of agro<br /> <br /> technologies in hydroponics.
2015 January-March
Product development and pre-launch testing procedures of strawberry and salads cultivation models.
2015 March-June
Mobile Apps for iOS and Android development. Obtaining required licenses.
2015 August
First appliances sales start in the Asian market (the Gulf and CIS states).
2016 December - 2017 August
First stage of ATF farms development for cannabis cultivation. Pre-start testing procedures of ATF cannabis grower.
2017 September-November
Preparation procedures for Pre ICO stage.
2017 December
the Pre ICO campaign
2018 January - February
Preparation procedures for ICO stage.
2018 February
the ICO campaign
2018 March
The enterprise development. Collected funds will be put on the Estonian company account then transfer from Estonia to ATF Canada in order to start project realization. Submitting documents to obtain necessary licenses. ATF tokens official listing.
2018 March - July
Production facilities erection and set-up activities. Pre-sale marketing activities.
2018 August
ATF product sales launch in USA.
2018 September
ATF product sales lunch in Canada.
2019 January
Pre-sale marketing activities worldwide and global sales official launch.
Ilya Tsigvintsev
CEO
No participating data
Alex Orlov
Industrial Designer
No participating data
Elena Sheromova
Economist
No participating data
Kirill Smirnov
Agro technology
No participating data
Anna Sukhareva
Agriculturist
No participating data
Anna Jurina
Senior Agronomist
No participating data
Alexey Kovnerchuk
Engineer
No participating data
Alexander Kolpakov
IT
Participates in a number of projects

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Svandis
The Svandis ecosystem is driven by a community of users and researchers using powerful Svandis tools, analytics, and indicators for professional traders in need of real-time, actionable data and analyses. The Svandis community drives the rapid collection of verifiable data and information through a tokenized incentive system. The platform within the ecosystem provides leading financial research, analytical and visualisation tools for anyone actively involved in the space: short-term and swing traders, traditional holders, analysts, hedge funds, institutional investors, trading firms, and token sale contributors.
Active
Zwoop
Using AI and blockchain, Zwoop’s unique find engine helps shoppers find the products they want from any website, at the best available price with a single click checkout. Shoppers will be able to pay for products using cryptocurrency and ZWP tokens.
Upcoming
Unchainet
UNCHAINET connects underutilized server resources with clients who need them. Our blockchain protocols govern the network, align provider incentives with computing resource quality giving choices and transparency to the cloud client market.
Active
Review.Network
Review.Network is a project that aims to create a unique trusted high-intelligence user-company feedback platform based on blockchain and AI technologies. Review.Network provides direct communication between companies and customers, that helps carry on efficient top-tier market research feedback without any mediator. Our model also directly rewards participants for their valuable feedback. The platform's community can gain coins by producing content and working with quality reviews on the Review.Network platform. With the smart recommendation system implemented, it is easier for members to find the best goods and services with ease. The REW is the digital currency of the Review.Network platform. Companies purchase coins to conduct market research on the platform and reward users in exchange for the feedback they leave.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.